Adalimumab/etanerceptCerebral toxoplasmosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1613卷 / 1期

关键词：

D O I：

10.1007/s40278-016-19971-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：13 / 13

相关论文

共 50 条

[31] Adalimumab/etanerceptHepatotoxicity: case report
Reactions Weekly, 2012, 1389 (1) : 7 - 7
[32] Adalimumab/infliximabOsteomyelitis: case report
Reactions Weekly, 2019, 1761 (1) : 19 - 19
[33] Adalimumab/etanerceptTuberculosis: case report
Reactions Weekly, 2020, 1800 (1) : 17 - 17
[34] Adalimumab/etanerceptDementia: case report
Reactions Weekly, 2021, 1852 (1) : 21 - 21
[35] Adalimumab/infliximabKeratopathy: case report
Reactions Weekly, 2014, 1499 (1) : 5 - 5
[36] Adalimumab/etanerceptMenorrhagia: case report
Reactions Weekly, 2023, 1972 (1) : 23 - 23
[37] Adalimumab/infliximabPsoriasis: case report
Reactions Weekly, 2011, 1350 (1) : 8 - 8
[38] Adalimumab/infliximabThrombocytopenia: case report
Reactions Weekly, 2007, 1162 (1) : 5 - 5
[39] Adalimumab/infliximabArthritis: case report
Reactions Weekly, 2015, 1548 (1) : 17 - 17
[40] Adalimumab/etanerceptBradypnoea: case report
Reactions Weekly, 2022, 1927 (1) : 22 - 22

← 1 2 3 4 5 →